Literature DB >> 3147470

Tolerance and selective cross-tolerance to the motivational effects of opioids.

T S Shippenberg1, M W Emmett-Oglesby, F J Ayesta, A Herz.   

Abstract

The issue of whether tolerance develops to the motivational effects of opioids was addressed by use of an unbiased place preference conditioning procedure. Administration of the mu-opioid agonists morphine or fentanyl produced dose-related preferences for the drug-associated place in control rats. In contrast, the kappa-opioid agonist, U-69593 produced conditioned place aversions. Non-contingent administration of morphine (5.0 mg/kg/12 h) for 4 days prior to conditioning resulted in tolerance to its reinforcing effects, and cross-tolerance to the effects of fentanyl. No cross-tolerance to the motivational effects of the psychostimulant d-amphetamine or the kappa-opioid agonist U-69593 was observed. Chronic administration of U-69593 prior to conditioning produced tolerance to its aversive effects. This treatment did not, however, modify the reinforcement produced by morphine. These data demonstrate that tolerance develops to both the reinforcing and aversive properties of opioids and suggest that differential cross-tolerance may provide a useful method for determining the pharmacological basis underlying drug-induced motivational effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3147470     DOI: 10.1007/bf02431542

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine.

Authors:  M W Emmett-Oglesby; T S Shippenberg; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

2.  Differential effects of mu and kappa opioid systems on motivational processes.

Authors:  T S Shippenberg; A Herz
Journal:  NIDA Res Monogr       Date:  1986

3.  [3H]U-69593 a highly selective ligand for the opioid kappa receptor.

Authors:  R A Lahti; M M Mickelson; J M McCall; P F Von Voigtlander
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

4.  Psychotomimesis mediated by kappa opiate receptors.

Authors:  A Pfeiffer; V Brantl; A Herz; H M Emrich
Journal:  Science       Date:  1986-08-15       Impact factor: 47.728

5.  Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model.

Authors:  S Siegel
Journal:  Science       Date:  1976-07-23       Impact factor: 47.728

6.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

Review 7.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

8.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

Review 9.  Motivational effects of opioids: evidence on the role of endorphins in mediating reward or aversion.

Authors:  I P Stolerman
Journal:  Pharmacol Biochem Behav       Date:  1985-11       Impact factor: 3.533

10.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  7 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Increased rewarding properties of morphine in dopamine-transporter knockout mice.

Authors:  C Spielewoy; F Gonon; C Roubert; V Fauchey; M Jaber; M G Caron; B P Roques; M Hamon; C Betancur; R Maldonado; B Giros
Journal:  Eur J Neurosci       Date:  2000-05       Impact factor: 3.386

3.  Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats.

Authors:  M Gaiardi; M Bartoletti; A Bacchi; C Gubellini; M Costa; M Babbini
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 4.  Reinforcement processes in opiate addiction: a homeostatic model.

Authors:  G Schulteis; G F Koob
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Naloxone blockade of amphetamine place preference conditioning.

Authors:  K A Trujillo; J D Belluzzi; L Stein
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 6.  Animal models of drug withdrawal symptoms.

Authors:  M W Emmett-Oglesby; D A Mathis; R T Moon; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Effects of combined opioids on pain and mood in mammals.

Authors:  Richard H Rech; David J Mokler; Shannon L Briggs
Journal:  Pain Res Treat       Date:  2012-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.